Improving Survival in Pancreatic Cancer with Platinum-Based Chemotherapy

A small study of adults with the most common form of pancreatic cancer adds to evidence that patients with BRCA1 or BRCA2 gene mutations long linked to a high risk of breast cancer have poorer overall survival rates than those without the mutations.

Provided by EUPB - Read the full story at the source site.
Read The Full Story

Top News